• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺铂/DNA加合物形成减少与人类头颈癌细胞系中的顺铂耐药相关。

Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines.

作者信息

Yang Z, Faustino P J, Andrews P A, Monastra R, Rasmussen A A, Ellison C D, Cullen K J

机构信息

Lombardi Cancer Center, Georgetown University, Washington, DC 20007, USA.

出版信息

Cancer Chemother Pharmacol. 2000;46(4):255-62. doi: 10.1007/s002800000167.

DOI:10.1007/s002800000167
PMID:11052622
Abstract

PURPOSE

To evaluate the correlation between cisplatin sensitivity, intracellular glutathione, and platinum/DNA adduct formation (measured by atomic absorption spectroscopy) in a series of seven head and neck cancer cell lines, and to evaluate the effect of biochemical modulation of glutathione on platinum/DNA adduct formation and repair.

METHODS

Cisplatin/DNA adducts were measured by atomic absorption spectroscopy. Glutathione content was measured by enzymatic assay and was modulated with buthionine sulfoximine. Apoptosis was measured by double-labeled flow cytometry.

RESULTS

Intracellular glutathione concentration was strongly correlated with cisplatin resistance (P = 0.002, R2 = 0.7). There was also a statistically significant inverse correlation between cisplatin/DNA adduct formation and the IC50 for cisplatin in these cell lines. (P = 0.0004, R2 = 0.67). In addition, resistant cells were able to repair approximately 70% of cisplatin/DNA adducts at 24 h, while sensitive cells repaired less than 28% of adducts in the same period. However, despite the positive correlation between cellular glutathione and cisplatin resistance, there was no direct correlation between intracellular glutathione concentration and platinum/DNA adduct formation. Further, depletion of intracellular glutathione by buthionine sulfoximine did not dramatically alter formation of cisplatin/DNA adducts even though it resulted in marked increase in cisplatin cytotoxicity and was associated with increased apoptosis.

CONCLUSIONS

These results suggest that glutathione has multiple effects not directly related to formation of cisplatin/DNA adducts, but may also be an important determinant of the cell's ability to repair cisplatin-induced DNA damage and resist apoptosis.

摘要

目的

评估一系列七种头颈癌细胞系中顺铂敏感性、细胞内谷胱甘肽与铂/DNA加合物形成(通过原子吸收光谱法测量)之间的相关性,并评估谷胱甘肽的生化调节对铂/DNA加合物形成和修复的影响。

方法

通过原子吸收光谱法测量顺铂/DNA加合物。通过酶促测定法测量谷胱甘肽含量,并用丁硫氨酸亚砜胺进行调节。通过双标记流式细胞术测量细胞凋亡。

结果

细胞内谷胱甘肽浓度与顺铂耐药性密切相关(P = 0.002,R2 = 0.7)。在这些细胞系中,顺铂/DNA加合物形成与顺铂的IC50之间也存在统计学上显著的负相关(P = 0.0004,R2 = 0.67)。此外,耐药细胞在24小时内能够修复约70%的顺铂/DNA加合物,而敏感细胞在同一时期修复的加合物不到28%。然而,尽管细胞内谷胱甘肽与顺铂耐药性呈正相关,但细胞内谷胱甘肽浓度与铂/DNA加合物形成之间没有直接相关性。此外,丁硫氨酸亚砜胺耗尽细胞内谷胱甘肽,即使它导致顺铂细胞毒性显著增加并与细胞凋亡增加相关,但并未显著改变顺铂/DNA加合物的形成。

结论

这些结果表明,谷胱甘肽具有多种与顺铂/DNA加合物形成不直接相关的作用,但也可能是细胞修复顺铂诱导的DNA损伤和抵抗细胞凋亡能力的重要决定因素。

相似文献

1
Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines.顺铂/DNA加合物形成减少与人类头颈癌细胞系中的顺铂耐药相关。
Cancer Chemother Pharmacol. 2000;46(4):255-62. doi: 10.1007/s002800000167.
2
Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis.顺铂优先结合头颈部鳞状细胞癌线粒体膜中的线粒体DNA和电压依赖性阴离子通道蛋白:在细胞凋亡中的可能作用。
Clin Cancer Res. 2006 Oct 1;12(19):5817-25. doi: 10.1158/1078-0432.CCR-06-1037.
3
In vitro studies on the mechanisms of oxaliplatin resistance.奥沙利铂耐药机制的体外研究
Cancer Chemother Pharmacol. 2001 Nov;48(5):398-406. doi: 10.1007/s002800100363.
4
Glutathione content but not gamma glutamyl cysteine synthetase mRNA expression predicts cisplatin resistance in head and neck cancer cell lines.
Cancer Chemother Pharmacol. 1997;40(1):75-80. doi: 10.1007/s002800050629.
5
Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo.顺铂在人头颈部癌中的药效学:铂含量、DNA加合物水平与体内外药物敏感性之间的相关性
Br J Cancer. 1999 Jan;79(1):82-8. doi: 10.1038/sj.bjc.6690015.
6
Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.口服铂类药物JM216在三种对顺铂敏感和耐药的人卵巢癌细胞系中对Pt/DNA损伤的基因特异性修复及凋亡诱导作用
Br J Cancer. 1999 Dec;81(8):1294-303. doi: 10.1038/sj.bjc.6694381.
7
Role of carrier ligand in platinum resistance of human carcinoma cell lines.载体配体在人癌细胞系铂耐药中的作用。
Cancer Res. 1993 Feb 15;53(4):799-805.
8
Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.顺铂敏感性与体外两种人卵巢癌细胞系中铂-DNA加合物形成及清除之间的异常关系。
Cancer Res. 1991 Sep 1;51(17):4557-64.
9
Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines.在不相关的人卵巢癌细胞系中,铂 - DNA损伤耐受性增加与顺铂耐药性以及对各种化疗药物的交叉耐药性相关。
Cancer Res. 1997 Mar 1;57(5):850-6.
10
Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy.细胞因子和药代动力学对接受顺铂治疗的儿童白细胞中铂-DNA加合物形成的影响。
Clin Cancer Res. 2001 Aug;7(8):2205-12.

引用本文的文献

1
Bulky Adducts in Clustered DNA Lesions: Causes of Resistance to the NER System.成簇DNA损伤中的大分子加合物:对核苷酸切除修复(NER)系统产生抗性的原因。
Acta Naturae. 2022 Oct-Dec;14(4):38-49. doi: 10.32607/actanaturae.11741.
2
Perftoran Inhibits Hypoxia-Associated Resistance in Lung Cancer Cells to Carboplatin.百扶然抑制肺癌细胞对卡铂的缺氧相关耐药性。
Front Pharmacol. 2022 Mar 24;13:860898. doi: 10.3389/fphar.2022.860898. eCollection 2022.
3
DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine.
来自抗癌药物的DNA加合物作为精准医学的候选预测标志物。
Chem Res Toxicol. 2017 Jan 17;30(1):388-409. doi: 10.1021/acs.chemrestox.6b00380. Epub 2017 Jan 3.
4
Selective inhibition of tumor cell associated Vacuolar-ATPase 'a2' isoform overcomes cisplatin resistance in ovarian cancer cells.选择性抑制肿瘤细胞相关液泡型 ATP 酶 'a2' 同工型可克服卵巢癌细胞对顺铂的耐药性。
Mol Oncol. 2016 Jun;10(6):789-805. doi: 10.1016/j.molonc.2016.01.003. Epub 2016 Jan 29.
5
Reduced glutathione: a radioprotector or a modulator of DNA-repair activity?还原型谷胱甘肽:辐射防护剂还是 DNA 修复活性调节剂?
Nutrients. 2013 Feb 7;5(2):525-42. doi: 10.3390/nu5020525.
6
Human MLH1 status can potentially predict cisplatin sensitivity but not microsatellite instability in head and neck squamous cell carcinoma cells.人类错配修复蛋白1(MLH1)的状态可能预测头颈部鳞状细胞癌细胞对顺铂的敏感性,但不能预测微卫星不稳定性。
Exp Ther Med. 2010 Jan;1(1):93-96. doi: 10.3892/etm_00000017. Epub 2010 Jan 1.
7
Adenylate kinase 3 sensitizes cells to cigarette smoke condensate vapor induced cisplatin resistance.腺苷酸激酶 3 使细胞对香烟烟雾冷凝物诱导的顺铂耐药性敏感。
PLoS One. 2011;6(6):e20806. doi: 10.1371/journal.pone.0020806. Epub 2011 Jun 15.
8
Cellular uptake and cytoplasm / DNA distribution of cisplatin and oxaliplatin and their liposomal formulation in human colorectal cancer cell HCT116.顺铂和奥沙利铂及其脂质体剂型在人结直肠癌细胞 HCT116 中的细胞摄取和细胞质/DNA 分布。
Invest New Drugs. 2011 Dec;29(6):1321-7. doi: 10.1007/s10637-010-9494-3. Epub 2010 Jul 24.
9
Hyperphosphorylation of replication protein A in cisplatin-resistant and -sensitive head and neck squamous cell carcinoma cell lines.顺铂耐药和敏感的头颈部鳞状细胞癌细胞系中复制蛋白 A 的过度磷酸化。
Head Neck. 2010 May;32(5):636-45. doi: 10.1002/hed.21234.
10
Hexokinase II detachment from the mitochondria potentiates cisplatin induced cytotoxicity through a caspase-2 dependent mechanism.己糖激酶II从线粒体上脱离通过半胱天冬酶-2依赖性机制增强顺铂诱导的细胞毒性。
Cell Cycle. 2009 Oct 15;8(20):3355-64. doi: 10.4161/cc.8.20.9853. Epub 2009 Oct 19.